ATE458476T1 - Verfahren für die zubereitung der amorphen form eines medikamentes - Google Patents
Verfahren für die zubereitung der amorphen form eines medikamentesInfo
- Publication number
- ATE458476T1 ATE458476T1 AT05758626T AT05758626T ATE458476T1 AT E458476 T1 ATE458476 T1 AT E458476T1 AT 05758626 T AT05758626 T AT 05758626T AT 05758626 T AT05758626 T AT 05758626T AT E458476 T1 ATE458476 T1 AT E458476T1
- Authority
- AT
- Austria
- Prior art keywords
- medication
- preparing
- amorphic form
- amorphic
- preparation
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B11/00—Machines or apparatus for drying solid materials or objects with movement which is non-progressive
- F26B11/12—Machines or apparatus for drying solid materials or objects with movement which is non-progressive in stationary drums or other mainly-closed receptacles with moving stirring devices
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/041—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum for drying flowable materials, e.g. suspensions, bulk goods, in a continuous operation, e.g. with locks or other air tight arrangements for charging/discharging
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57621604P | 2004-06-01 | 2004-06-01 | |
| US58377804P | 2004-06-28 | 2004-06-28 | |
| US59970004P | 2004-08-05 | 2004-08-05 | |
| PCT/US2005/019485 WO2005117837A1 (en) | 2004-06-01 | 2005-06-01 | Process for preparation of amorphous form of a drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE458476T1 true ATE458476T1 (de) | 2010-03-15 |
Family
ID=35134738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05758626T ATE458476T1 (de) | 2004-06-01 | 2005-06-01 | Verfahren für die zubereitung der amorphen form eines medikamentes |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7589128B2 (de) |
| JP (1) | JP2008500405A (de) |
| KR (1) | KR20060123772A (de) |
| AT (1) | ATE458476T1 (de) |
| CA (1) | CA2560984A1 (de) |
| DE (1) | DE602005019509D1 (de) |
| DK (1) | DK1641438T3 (de) |
| ES (1) | ES2339682T3 (de) |
| IL (1) | IL179719A0 (de) |
| MX (1) | MXPA06010084A (de) |
| WO (1) | WO2005117837A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060083784A1 (en) * | 2002-08-07 | 2006-04-20 | Smithkline Beecham Corporation | Amorphous pharmaceutical compositions |
| US7501448B2 (en) | 2004-10-15 | 2009-03-10 | Teva Pharmaceutical Industries, Ltd. | Process for preparing telmisartan |
| MX2007005348A (es) * | 2004-11-03 | 2007-06-25 | Teva Pharma | Formas amorfas y polimorficas de sodio de telmisartan. |
| WO2006060615A1 (en) | 2004-12-01 | 2006-06-08 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Non-hygroscopic and powdery amorphous pimecrolimus |
| WO2006079921A2 (en) | 2005-01-28 | 2006-08-03 | Pfizer Products Inc. | Drying of drug-containing particles |
| US7812168B2 (en) | 2005-07-05 | 2010-10-12 | Teva Pharmaceutical Industries Ltd. | Purification of montelukast |
| US20070161796A1 (en) * | 2005-11-16 | 2007-07-12 | Ilan Kor-Sade | Drying methods of montelukast sodium by azeotropic removal of the solvent |
| GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
| US8834929B2 (en) | 2006-07-21 | 2014-09-16 | Bend Research, Inc. | Drying of drug-containing particles |
| GB2441328A (en) * | 2006-08-30 | 2008-03-05 | Alpharma Aps | A method for obtaining mupirocin calcium |
| US20080187684A1 (en) * | 2007-02-07 | 2008-08-07 | Imra America, Inc. | Method for depositing crystalline titania nanoparticles and films |
| US20090234125A1 (en) * | 2007-11-26 | 2009-09-17 | Eli Lancry | Amorphous retapamulin and processes for preparation thereof |
| GB2457452B (en) * | 2008-02-12 | 2010-05-12 | Pliva Lachema As | Amorphous form of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) amminedichloroplatinum (IV) |
| EP2366378A1 (de) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Donepezilformulierungen mit verzögerter Freisetzung |
| WO2011121596A2 (en) * | 2010-04-01 | 2011-10-06 | Neuland Laboratories Ltd. | Crystal modification of moxifloxacin hydrochloride |
| US8471030B2 (en) | 2010-12-06 | 2013-06-25 | Orochem Technologies Inc. | Purification of montelukast using simulated moving bed |
| AU2019334202A1 (en) | 2018-09-06 | 2021-03-25 | Innopharmascreen, Inc. | Methods and compositions for treatment of asthma or parkinson's disease |
| WO2025146702A1 (en) * | 2024-01-03 | 2025-07-10 | Msn Laboratories Private Limited, R&D Center | Solid state forms of 1-{(2s,5r)-2-methyl-5-[(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino] piperidine-1-yl}prop-2-en-1-one 4-methylbenzene-1-sulfonic acid |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643240A1 (de) | 1966-09-16 | 1971-06-24 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane |
| US3977943A (en) | 1971-06-12 | 1976-08-31 | Beecham Group Limited | Antibiotics |
| GB1395907A (en) | 1971-06-12 | 1975-05-29 | Beecham Group Ltd | Antibiotics |
| US4071536A (en) | 1971-06-12 | 1978-01-31 | Beecham Group Limited | Antibiotics |
| JPS5270083A (en) | 1975-12-04 | 1977-06-10 | Yoshitomi Pharmaceut Ind Ltd | Manufacture of an antibiotics, trans-pseudomonic acid |
| GB1577730A (en) | 1976-10-23 | 1980-10-29 | Beecham Group Ltd | Treatment of infections with pseudomonicacid salts or esters thereof |
| GB1577545A (en) | 1977-07-27 | 1980-10-22 | Beecham Group Ltd | Treatment of swine dysenter |
| CA1103264A (en) | 1977-09-30 | 1981-06-16 | Norman H. Rogers | Purification of pseudomonic acid |
| CA1115699A (en) | 1978-05-20 | 1982-01-05 | Alan D. Curzons | Lithium pseudomonate and its preparation |
| CA1196284A (en) | 1982-05-28 | 1985-11-05 | Joshua Oduro-Yeboah | Pharmaceutical formulations |
| GB8415579D0 (en) | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
| GB8428952D0 (en) | 1984-11-16 | 1984-12-27 | Beecham Group Plc | Formulations |
| GB8530796D0 (en) | 1985-12-13 | 1986-01-22 | Beecham Group Plc | Pharmaceutical composition |
| IE59628B1 (en) | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
| US5594026A (en) | 1990-12-11 | 1997-01-14 | Smithkline Beecham Group P.L.C. | Polymorphs of crystalline mupirocin |
| US5292892A (en) | 1991-05-07 | 1994-03-08 | Sankyo Company, Limited | Anti-bacterial compound and pharmaceutical compositions thereof |
| US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| JP2001504091A (ja) | 1996-10-01 | 2001-03-27 | スミスクライン・ビーチャム・コーポレイション | 病原性生物による鼻咽腔のコロニー形成に関連する細菌感染の治療のための薬剤の製造のためのミュピロシンの使用 |
| AU5459698A (en) * | 1997-11-26 | 1999-06-15 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| US6306345B1 (en) * | 1998-05-06 | 2001-10-23 | Universal Preservation Technologies, Inc. | Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures |
| CN1670217A (zh) | 1999-02-03 | 2005-09-21 | 特瓦药厂有限公司 | 经微生物学方法制备假单胞菌酸a抗生素的方法 |
| CZ20012725A3 (cs) | 1999-02-03 | 2002-03-13 | Biogal Gyogyszergyar Rt. | Způsob izolace kyseliny pseudomonové z kultivačního bujonu obsahujícího komplex kyseliny pseudomonové |
| IN191492B (de) | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| US6335023B1 (en) | 1999-06-30 | 2002-01-01 | Ruey J. Yu | Oligosaccharide aldonic acids and their topical use |
| US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
| IL137363A (en) | 2000-07-18 | 2005-12-18 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| HUP0500797A2 (en) | 2001-06-21 | 2007-06-28 | Biogal Gyogyszergyar | Metabolic controlled fermentation process for pseudomonic acid production |
| WO2003006595A1 (fr) | 2001-07-11 | 2003-01-23 | Rhodia Chimie | Procede de nettoyage d'une surface a l'aide d'une composition aqueuse contenant un polymere en dispersion |
| EP1455769A4 (de) | 2001-12-28 | 2004-09-22 | Biogal Gyogyszergyar | Verfahren zur herstellung von kristallinem und amorphem mupirocin-calcium |
| PL372247A1 (en) | 2002-02-01 | 2005-07-11 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| EP1469830A2 (de) | 2002-02-01 | 2004-10-27 | Pfizer Products Inc. | Verfahren zur herstellung homogenisierter sprühgetrockneter fester amorpher wirkstoffdispersionen, das düsen verwendet |
| IL150907A (en) | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
| WO2006060615A1 (en) | 2004-12-01 | 2006-06-08 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Non-hygroscopic and powdery amorphous pimecrolimus |
-
2005
- 2005-06-01 AT AT05758626T patent/ATE458476T1/de not_active IP Right Cessation
- 2005-06-01 CA CA002560984A patent/CA2560984A1/en not_active Abandoned
- 2005-06-01 KR KR1020067018664A patent/KR20060123772A/ko not_active Ceased
- 2005-06-01 MX MXPA06010084A patent/MXPA06010084A/es unknown
- 2005-06-01 DK DK05758626.5T patent/DK1641438T3/da active
- 2005-06-01 US US11/143,312 patent/US7589128B2/en not_active Expired - Fee Related
- 2005-06-01 ES ES05758626T patent/ES2339682T3/es not_active Expired - Lifetime
- 2005-06-01 DE DE602005019509T patent/DE602005019509D1/de not_active Expired - Lifetime
- 2005-06-01 JP JP2007527596A patent/JP2008500405A/ja active Pending
- 2005-06-01 WO PCT/US2005/019485 patent/WO2005117837A1/en not_active Ceased
-
2006
- 2006-11-30 IL IL179719A patent/IL179719A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20050272768A1 (en) | 2005-12-08 |
| IL179719A0 (en) | 2007-05-15 |
| ES2339682T3 (es) | 2010-05-24 |
| KR20060123772A (ko) | 2006-12-04 |
| MXPA06010084A (es) | 2007-03-01 |
| DE602005019509D1 (de) | 2010-04-08 |
| CA2560984A1 (en) | 2005-12-15 |
| US7589128B2 (en) | 2009-09-15 |
| WO2005117837A1 (en) | 2005-12-15 |
| JP2008500405A (ja) | 2008-01-10 |
| DK1641438T3 (da) | 2010-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005019509D1 (de) | Verfahren für die zubereitung der amorphen form eines medikamentes | |
| GEP20105082B (en) | (biphenyl) carboxylic acids and derivatives thereof | |
| MXPA05009068A (es) | Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos. | |
| GEP20125425B (en) | Biaryl ether urea compounds | |
| IL193951A (en) | A compound with central pyrrolidine units, an intermediate compound for the preparation of the mediated compound, a process for the production of the mediated compound, the use of a mediated compound for the manufacture of a drug, a pharmaceutical preparation, a method for the preparation of a pharmaceutical preparation, and a method for making conventional pharmaceutical salt of a non-salts compound. | |
| ATE556074T1 (de) | Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| ATE522529T1 (de) | Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst | |
| CR10206A (es) | Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
| NO20075557L (no) | Krystaller av morfinanderivat og fremgangsmate for fremstilling derav | |
| NZ600786A (en) | Proteasome inhibitors and processes for their preparation, purification and use | |
| ATE444950T1 (de) | Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid | |
| MX2021011823A (es) | Derivado pirroloheterociclico, metodo de preparacion del mismo y su aplicacion en medicina. | |
| DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
| EA200801893A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления | |
| ATE536864T1 (de) | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung | |
| ATE500226T1 (de) | Aripiprazolhemifumarat und verfahren zu dessen herstellung | |
| EP4429611A4 (de) | Verfahren zur verabreichung eines arzneimittels an die netzhaut | |
| ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
| NO20091334L (no) | Fremgangsmate for syntese av klopidogrel og nye former for farmasoytisk akseptable salter derav | |
| PH12022550254A1 (en) | MICROMOLECULE PI4KIIIa INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | |
| ATE374172T1 (de) | Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
| ATE344259T1 (de) | Verfahren und zwischenprodukte für die herstellung von emtricitabin | |
| ATE528301T1 (de) | Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen | |
| MX2012002529A (es) | Agente terapeutico para trastornos de ansiedad. | |
| BRPI0517369A (pt) | compostos, processo para a sua manufatura, composições que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |